U.S. Respiratory Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product Offering, By Distribution & Service Channel, By Notable States, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1 Research Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Objectives
  • 1.2.1 Objective - 1
  • 1.2.2 Objective - 2
  • 1.2.3 Objective - 3
• 1.3 List of Secondary Sources
• 1.4 List of Abbreviation

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Product and End Use Outlook
• 2.3 Competitive Landscape

Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis

• 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
• 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
• 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
  • 3.3.1 Sleep Apnea Devices
    • 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
    • 3.3.1.2 Auto-titrating CPAP
    • 3.3.1.3 Fixed CPAP
    • 3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
    • 3.3.1.5 Integrated Humidifiers
  • 3.3.2 Oxygen Therapy
    • 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million)
    • 3.3.2.2 Stationary Oxygen Concentrators
    • 3.3.2.3 Portable Oxygen Concentrators (POCs)
    • 3.3.2.4 Cylinders & regulators
    • 3.3.2.5 Conservers
  • 3.3.3 Nebulizer Therapy Equipment
    • 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
    • 3.3.3.2 Compressor nebulizers
    • 3.3.3.3 Mesh Nebulizers
    • 3.3.3.4 Drug-specific Nebulizers
  • 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million)
    • 3.3.4.2 CPAP Masks & Cushions
    • 3.3.4.3 Oxygen tubing & filters
    • 3.3.4.4 Humidifier Chambers
    • 3.3.4.5 Bacterial/Viral (B/V)
    • 3.3.4.6 Aerosol Delivery Accessories
  • 3.3.5 Home & Transport Ventilators
    • 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million)
    • 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
    • 3.3.5.3 Portable Ventilators (Transport/ALS)

Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis

• 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
• 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
• 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
  • 4.3.1 National Dme Networks
    • 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million)
  • 4.3.2 Regional Independents
    • 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million)
  • 4.3.3 Hospital/Idn Homecare Extensions
    • 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million)
  • 4.3.4 Online Dme Retailers
    • 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)

Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million)

• 5.1 Midwest
  • 5.1.1 Nebraska
    • 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.1.2 Demand & Patient Population
      • 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.1.3 Supplier Density & Network Mapping
    • 5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.1.5.1 Sleep Clinics
      • 5.1.1.5.2 Pulmonologists
      • 5.1.1.5.3 Hospitals
      • 5.1.1.5.4 Other providers
    • 5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.1.7 Research Methodology
  • 5.1.2 IOWA
    • 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.2.2 Demand & Patient Population
      • 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
      • 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
      • 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
      • 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
    • 5.1.2.3 Supplier Density & Network Mapping
    • 5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.2.5.1 Sleep Clinics
      • 5.1.2.5.2 Pulmonologists
      • 5.1.2.5.3 Hospitals
      • 5.1.2.5.4 Other providers
    • 5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.2.1 Research Methodology
  • 5.1.3 KANSAS
    • 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.3.2 Demand & Patient Population
      • 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.3.3 Supplier Density & Network Mapping
    • 5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.3.5.1 Sleep Clinics
      • 5.1.3.5.2 Pulmonologists
      • 5.1.3.5.3 Hospitals
      • 5.1.3.5.4 Other providers
    • 5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.3.7 Research Methodology
  • 5.1.4 SOUTH DAKOTA
    • 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.4.2 Demand & Patient Population
      • 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.4.3 Supplier Density & Network Mapping
    • 5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.4.5.1 Sleep Clinics
      • 5.1.4.5.2 Pulmonologists
      • 5.1.4.5.3 Hospitals
      • 5.1.4.5.4 Other providers
    • 5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.4.7 Research Methodology
  • 5.1.5 North Dakota
    • 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.5.2 Demand & Patient Population
      • 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.5.3 Supplier Density & Network Mapping
    • 5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.5.5.1 Sleep Clinics
      • 5.1.5.5.2 Pulmonologists
      • 5.1.5.5.3 Hospitals
      • 5.1.5.5.4 Other providers
    • 5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.5.7 Research Methodology
  • 5.1.6 Missouri
    • 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.6.2 Demand & Patient Population
      • 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.6.3 Supplier Density & Network Mapping
    • 5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.6.5.1 Sleep Clinics
      • 5.1.6.5.2 Pulmonologists
      • 5.1.6.5.3 Hospitals
      • 5.1.6.5.4 Other providers
    • 5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.6.7 Research Methodology
  • 5.1.7 Minnesota
    • 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.7.2 Demand & Patient Population
      • 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.7.3 Supplier Density & Network Mapping
    • 5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.7.5.1 Sleep Clinics
      • 5.1.7.5.2 Pulmonologists
      • 5.1.7.5.3 Hospitals
      • 5.1.7.5.4 Other providers
    • 5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.7.7 Research Methodology
  • 5.1.8 Wisconsin
    • 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.8.2 Demand & Patient Population
      • 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.8.3 Supplier Density & Network Mapping
    • 5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.8.5.1 Sleep Clinics
      • 5.1.8.5.2 Pulmonologists
      • 5.1.8.5.3 Hospitals
      • 5.1.8.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.8.7 Research Methodology
  • 5.1.9 Illinois
    • 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.9.2 Demand & Patient Population
      • 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.9.3 Supplier Density & Network Mapping
    • 5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.9.5.1 Sleep Clinics
      • 5.1.9.5.2 Pulmonologists
      • 5.1.9.5.3 Hospitals
      • 5.1.9.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.9.7 Research Methodology
  • 5.1.10 Colorado
    • 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.10.2 Demand & Patient Population
      • 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.10.3 Supplier Density & Network Mapping
    • 5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.10.5.1 Sleep Clinics
      • 5.1.10.5.2 Pulmonologists
      • 5.1.10.5.3 Hospitals
      • 5.1.10.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.10.7 Research Methodology
  • 5.1.11 WYOMING
    • 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.11.2 Demand & Patient Population
      • 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.11.3 Supplier Density & Network Mapping
    • 5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.11.5.1 Sleep Clinics
      • 5.1.11.5.2 Pulmonologists
      • 5.1.11.5.3 Hospitals
      • 5.1.11.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.11.7 Research Methodology
  • 5.1.12 OHIO
    • 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.12.2 Demand & Patient Population
      • 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.12.3 Supplier Density & Network Mapping
    • 5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.12.5.1 Sleep Clinics
      • 5.1.12.5.2 Pulmonologists
      • 5.1.12.5.3 Hospitals
      • 5.1.12.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.12.7 Research Methodology
  • 5.1.13 INDIANA
    • 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.13.2 Demand & Patient Population
      • 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.13.3 Supplier Density & Network Mapping
    • 5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.13.5.1 Sleep Clinics
      • 5.1.13.5.2 Pulmonologists
      • 5.1.13.5.3 Hospitals
      • 5.1.13.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.13.7 Research Methodology

Chapter 6 Competitive Analysis

• 6.1 Participant's Overview
  • 6.1.1 Tier 1 (National DME Providers)
  • 6.1.2 Tier 2 (OEM Manufacturers)
  • 6.1.3 Tier 3 (Regional Independents)
• 6.2 Financial Performance
  • 6.2.1 Tier 1 (National DME Providers)
    • 6.2.1.1 Public Companies
    • 6.2.1.2 Private Companies
  • 6.2.2 Tier 2 (OEM Manufacturers)
    • 6.2.2.1 Public Companies
    • 6.2.2.2 Private Companies
  • 6.2.3 Tier 3 (Regional Independents)
    • 6.2.3.1 Private Companies
• 6.3 Product Benchmarking
  • 6.3.1 Tier 1 (National DME Providers)
    • 6.3.1.1 Sleep Apnea Devices
    • 6.3.1.2 Oxygen Therapy
      • 6.3.1.2.1 Portable Oxygen Concentrators
      • 6.3.1.2.2 Stationary Oxygen Concentrators
    • 6.3.1.3 Nebulizer Therapy Equipment
    • 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.1.5 Home & Transport Ventilators
  • 6.3.2 Tier 2 (OEM Manufacturers)
    • 6.3.2.1 Sleep Apnea Devices
    • 6.3.2.2 Oxygen Therapy
      • 6.3.2.2.1 Portable Oxygen Concentrators
      • 6.3.2.2.2 Stationary Oxygen Concentrators
    • 6.3.2.3 Nebulizer Therapy Equipment
    • 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.2.5 Home & Transport Ventilators
  • 6.3.3 Tier 3 (Regional Independents)
    • 6.3.3.1 Sleep Apnea Devices
    • 6.3.3.2 Oxygen Therapy
      • 6.3.3.2.1 Portable Oxygen Concentrators
      • 6.3.3.2.2 Stationary Oxygen Concentrators
    • 6.3.3.3 Nebulizer Therapy Equipment
    • 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.3.5 Home & Transport Ventilators
• 6.4 Participant Categorization
• 6.5 Company Market Position Analysis
  • 6.5.1 Tier 1 (National DME Providers)
  • 6.5.2 Tier 2 (OEM Manufacturers)
  • 6.5.1 Tier 3 (Regional Independents)
• 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
  • 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
    • 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare's Exit Strategy Aims to Realign the Company with its Mission and Vision
    • 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare's exit and its anticipated impact
  • 6.6.2 Philips Respironics
    • 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
  • 6.6.3 Fisher & Paykel Healthcare
    • 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
  • 6.6.4 Invacare
    • 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
    • 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
  • 6.6.5 Resmed
    • 6.6.5.1 ResMed's Exit Strategy from the Portable Oxygen Concentrator (POC) Market
  • 6.6.6 Medtronic
    • 6.6.6.1 Medtronic Exit Strategy
  • 6.6.7 Teleflex Incorporated
    • 6.6.7.1 Teleflex Incorporated Exit Strategy
  • 6.6.8 Breas Medical AB
    • 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
• 6.7 Strategy Mapping
  • 6.7.1 Tier 1 (National DME Providers)
    • 6.7.1.1 Mergers and Acquisitions
    • 6.7.1.2 Collaborations & Partnerships
  • 6.7.2 Tier 2 (OEM Manufacturers)
    • 6.7.2.1 New Product Launch
    • 6.7.2.2 Mergers and Acquisitions
    • 6.7.2.3 Other Strategies
  • 6.7.3 Tier 3 (Regional Independents)
    • 6.7.3.1 Mergers and Acquisitions
• 6.8 List of Other Market Players

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations
• Table 3 U.S. Respiratory Durable Medical Equipment Market, by Product Offering, 2021 - 2033 (USD Million)
• Table 4 U.S. Respiratory Durable Medical Equipment market, by Distribution & Service Channels, 2021 - 2033 (USD Million)
• Table 5 Reimbursement and Payer Landscape at Each Device Category for Nebraska
• Table 6 Regulatory & Licensing Framework for Nebraska
• Table 7 Reimbursement and Payer Landscape at Each Device Category for Iowa
• Table 8 Regulatory & Licensing Framework for Iowa
• Table 9 Reimbursement and Payer Landscape at Each Device Category for Kansas
• Table 10 Regulatory & Licensing Framework for Kansas
• Table 11 Reimbursement and Payer Landscape at Each Device Category for South Dakota
• Table 12 Regulatory & Licensing Framework for South Dakota
• Table 13 Reimbursement and Payer Landscape at Each Device Category for North Dakota
• Table 14 Regulatory & Licensing Framework for North Dakota
• Table 15 Reimbursement and Payer Landscape at Each Device Category for Missouri
• Table 16 Regulatory & Licensing Framework for Missouri
• Table 17 Reimbursement and Payer Landscape at Each Device Category for Minnesota
• Table 18 Regulatory & Licensing Framework for Minnesota
• Table 19 Reimbursement and Payer Landscape for Each Device Category for Wisconsin
• Table 20 Regulatory & Licensing Framework for Wisconsin
• Table 21 Reimbursement and Payer Landscape for Each Device Category for Illinois
• Table 22 Regulatory & Licensing Framework for Illinois
• Table 23 Reimbursement and Payer Landscape for Each Device Category for Colorado
• Table 24 Regulatory & Licensing Framework for Colorado
• Table 25 Reimbursement and Payer Landscape for Each Device Category for Wyoming
• Table 26 Regulatory & Licensing Framework for Wyoming
• Table 27 Reimbursement and Payer Landscape for Each Device Category for Ohio
• Table 28 Regulatory & Licensing Framework for Ohio
• Table 29 Reimbursement and Payer Landscape for Each Device Category for Indiana
• Table 30 Regulatory & Licensing Framework for Indiana

List of Figures

• Fig. 1 U.S. Respiratory DME Market Segmentation
• Fig. 2 Market snapshot
• Fig. 3 Product and end use outlook (USD Million)
• Fig. 4 Competitive landscape
• Fig. 5 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
• Fig. 6 U.S. Respiratory Durable Medical Equipment Market by Product Offering :Market Share Analysis, 2025 & 2033
• Fig. 7 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
• Fig. 8 Oxygen Therapy Market, 2021 - 2033 (USD Million)
• Fig. 9 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
• Fig. 10 Masks, Tubing, Filters & Resupply Items (Consumables) Market 2021 - 2033 (USD Million)
• Fig. 11 Home & Transport Ventilators Market 2021 - 2033 (USD Million)
• Fig. 12 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
• Fig. 13 U.S. Respiratory Durable Medical Equipment Market by Distribution & Service Channels : Market Share Analysis, 2025 & 2033
• Fig. 14 National DME Networks Market, 2021 - 2033 (USD Million)
• Fig. 15 Regional Independents Market 2021 - 2033 (USD Million)
• Fig. 16 Hospital/IDN Homecare Extensions Market 2021 - 2033 (USD Million)
• Fig. 17 Online DME Retailers Market 2021 - 2033 (USD Million)
• Fig. 18 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 19 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 20 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 21 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 22 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 23 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 24 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 25 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 26 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 27 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 28 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 29 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 30 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
• Fig. 31 Company/Competition Categorization (Distributors)
• Fig. 32 Company/Competition Categorization (Manufacturers)
• Fig. 33 Company Market Position Analysis (Tier 1 (National DME Providers) )
• Fig. 34 Company Market Position Analysis (Tier 2 (OEM Manufacturers))
• Fig. 35 Company Market Position Analysis (Tier 3 Regional Independents)
• Fig. 36 Strategy Mapping (National DME Providers)
• Fig. 37 Strategy Mapping (OEM Manufacturers)
• Fig. 38 Strategy mapping (Regional Independents)